Very-High-Dose Caspofungin Combined with Voriconazole To Treat Central Nervous System Aspergillosis: Substantial Penetration of Caspofungin into Cerebrospinal Fluid

Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohort

(2013) Herbert Spapen et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Experimental Central Nervous System Aspergillosis Therapy: Efficacy, Drug Levels and Localization, Immunohistopathology, and Toxicity

(2012) Karl V. Clemons et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Aspergillus meningitis: A rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases

(2012) Spinello Antinori et al.   JOURNAL OF INFECTION

Efficacy of Caspofungin in a Juvenile Mouse Model of Central Nervous System Candidiasis

(2011) Amy M. Flattery et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis

(2011) S. Schwartz et al.   INFECTION

Efficacy and Safety of Current Drug Therapies for Invasive Aspergillosis

(2011) Friederike Traunmüller et al.   PHARMACOLOGY

Detection of Circulating Aspergillus fumigatus DNA by Real-Time PCR Assay of Large Serum Volumes Improves Early Diagnosis of Invasive Aspergillosis in High-Risk Adult Patients under Hematologic Surveillance

(2008) F. Suarez et al.   JOURNAL OF CLINICAL MICROBIOLOGY